During lung development, cells proliferate for a defined length of time before they begin to differentiate. Factors that control this proliferative process and how this growth process is related to lung cancer are currently unknown. Here, we found that the WD40-containing protein (p44/wdr77) was expressed in growing epithelial cells at the early stages of lung development. In contrast, p44/wdr77 expression was diminished in fully differentiated epithelial cells in the adult lung. Loss of p44/wdr77 gene expression led to cell growth arrest and differentiation. Re-expression of p44/wdr77 caused terminally differentiated cells to re-enter the cell cycle. Our findings suggest that p44/wdr77 is essential and sufficient for proliferation of lung epithelial cells. P44/ Wdr77 was re-expressed in lung cancer, and silencing p44/wdr77 expression strongly inhibited growth of lung adenocarcinoma cells in tissue culture and abolished growth of lung adenocarcinoma tumor xenografts in mice. The growth arrest induced by loss of p44/wdr77 expression was partially through the p21-Rb signaling. Our results suggest that p44/wdr77 controls cellular proliferation during lung development, and this growth process is reactivated during lung tumorigenesis.
INTRODUCTION
Despite advances in detection and treatment modalities, lung cancer remains the leading cause of cancer-related death worldwide. 1, 2 Novel therapeutic targets for the disease are urgently needed. Such targets may include the factors that control cellular proliferation during normal lung development. The complex structure of the lung develops sequentially, first by the coordinated growth of a variety of lung cells and later by the functional differentiation of lung epithelial cells to synthesize lipoprotein surfactants. 3 Members of the fibroblast growth factor, transforming growth factor-b, and epidermal growth factor families, as well as the secreted morphogen sonic hedgehog, appear to have important regulatory roles in lung branching morphogenesis and epithelial cell differentiation. 4 However, the factors that control cellular proliferation during lung development largely remain uncharacterized. Researchers have found that many factors that control normal lung development also have key roles in injury repair, fibrosis and tumorigenesis in the lung. 1, 5 We purified and cloned a novel androgen receptor-interacting protein, designated p44/wdr77. 6, 7 P44/WDR77 localizes in the cytoplasm of the epithelial cell at the early stage of prostate development (the growing stage) and in the adult prostate, p44/ wdr77 in the nucleus establishes and maintains luminal epithelia in a growth-arrested fully differentiated state (the G 1 /G 0 cell cycle phase). [7] [8] [9] Previous studies' findings have indicated that p44/ wdr77 expression may be essential for lung cell growth and lung tumorigenesis. Lu et al. 10 used microarrays to characterize the transcriptional profiles of proximal and distal regions of the murine lung at embryonic day 11.5, when branching morphogenesis is initiated. They found that the p44/wdr77 gene was preferentially expressed in the branching regions of the murine embryonic lung, suggesting that p44/wdr77 is a modulator of cell growth in regions of branching tubules. In mice, overexpression of the transcriptional regulator Myc-the most frequently deregulated oncogene in human tumors-results in distinct types of lung adenocarcinoma. Reymann and Borlak 11 used microarray technology to identify alterations in the expression of genes based on a transgenic mouse model in which c-Myc overexpression in the alveolar epithelium resulted in the development of bronchioloalveolar carcinoma and papillary adenocarcinoma. In that study, c-Myc overexpression upregulated p44/wdr77 gene expression, and researchers observed similar results in N-Myc loss and gain of function in the murine lung. 11 Kuner et al. 12 detected p44/wdr77 expression in 58 lung tumor samples, and Wachi et al. 13 found that p44/wdr77 expression was significantly higher in lung cancer than in the normal lung cells. In addition, Gemma et al.
14 found that p44/wdr77 was highly expressed in all 29 lung cancer cell lines they examined. Taken together, these studies' findings indicate that p44/wdr77 expression may be essential for lung cell growth and lung tumorigenesis. However, despite these studies, the exact function of p44/wdr77 in lung development and in lung cancer remains unknown.
In the present study, we found that p44/wdr77 was highly expressed in mouse lung epithelial cells during the early stages of development, when cells are proliferating; however, p44/wdr77 expression was diminished in the adult lung. We also found that p44/wdr77 expression was essential and sufficient for lung epithelial cell growth, and that p44/wdr77 was highly expressed in lung tumor samples and lung cancer cell lines. Silencing p44/ wdr77 expression in lung adenocarcinoma cells abolished cell growth in tissue cultures and tumor xenografts in nude mice. In addition, p44/wdr77 regulated the growth of lung cancer cells partially through the p21-Rb-E2F signaling. Our findings indicate that p44/wdr77 has an important role in the growth of lung epithelial cells and lung cancer.
RESULTS
P44/wdr77 expression is associated with cell proliferation during lung development Immunostaining of mouse lung tissues with an anti-p44/wdr77 antibody was performed to detect the p44/wdr77 protein. We detected p44/wdr77 protein expression in epithelial (Figure 1a, black arrows) and alveolar (white arrows) cells in the lungs from 1-, 7-, or 14-day-old mice. The level of p44/wdr77 expression decreased as mice aged; at 30 days of age, only a few epithelial cells still expressed p44/wdr77 (Figure 1a , black arrows). Co-immunostaining of p44/wdr77 with CC10 revealed that the p44/wdr77-expressing cells are Clara cells but SP-C positive mature alveolar type II epithelial cells do not express p44/wdr77 (Supplementary Figure S1) . p44/wdr77 protein expression in the lung tissue of mice older than 120 days was undetectable. Consistent with this observation, western blot analysis revealed high levels of the expression of p44/wdr77 protein in lysates from the lungs of 1-, 7-, or 14-day-old mice ( Figure 1b, lanes 1-6) . Figure 1 . p44/wdr77 expression is associated with epithelial cell proliferation during lung development in mice. (a) p44/wdr77 expression in lung tissue at the early stages of development. Lung tissues obtained from mice 1 (n ¼ 5), 7 (n ¼ 5), 14 (n ¼ 5), 30 (n ¼ 5), 120 (n ¼ 5) or 390 (n ¼ 3) days old were immunostained for p44/wdr77 expression. p44/wdr77-expressing cells are stained brown. Black and white arrows indicate epithelial and alveolar cells, respectively. (b) Western blot analysis of protein extracts from the lungs of mice 1 (n ¼ 2), 7 (n ¼ 2), 14 (n ¼ 2), 30 (n ¼ 2), 120 (n ¼ 2) or 390 (n ¼ 1) days old using an anti-p44/wdr77 antibody. Actin (bottom panel) was used as the sample loading control. (c) Immunostaining of the proliferation marker (antigen Ki67) in lung tissues. Ki67-positive cells are stained brown. The percentages of Ki67-positive epithelial cells are indicated.
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The p44/wdr77 protein was weakly expressed in the lung cells of 21-, 30-, and 60-day-old mice (lanes 7-12) and not expressed in the lung cells of 120-and 390-day-old mice (lanes [13] [14] [15] . These findings indicated that p44/wdr77 expression was associated with early lung development.
Staining of mouse lung tissues for the proliferation marker Ki67 (Figure 1c ) revealed a significant proportion (mean±standard error of the mean (s.e.m.), 17±3%) of proliferative lung cells in 1-day-old mice. We found smaller proportions of proliferative lung cells in 7-day-old mice (mean ± s.e.m., 15 ± 2%) and 14-day-old mice (mean±s.e.m., 4.5±0.5%). The proportions of proliferating epithelial cells were even lower in the lungs of 30-day-old mice (mean ± s.e.m., 3.1 ± 0.4%), 120-day-old mice (mean ± s.e.m., 0.7 ± 0.2%) and 390-day-old mice (mean ± s.e.m., 0.6 ± 0.1%). These findings suggested that p44/wdr77 expression was associated with the proliferation of lung epithelial cells.
P44/wdr77 expression is sufficient to drive lung epithelial cell growth Investigators have used a transgenic mouse strain (H-2K b -tsA58) whose tissues harbor a temperature-sensitive simian virus 40 large tumor antigen (LTA), to isolate and propagate primary cells from different organs for long-term culture. 15, 16 We used this mouse strain to generate primary cultures of mouse lung epithelial cells. We isolated epithelial cells from the lung and cultured them at a permissive temperature (33 1C) . At this temperature, the LTA is expressed in lung epithelial cells (Figure 2b , lane 1, top panel), and epithelial cells are immortal. Isolated epithelial cells (lung ECs (LTA ts )) had high levels of expression of cytokeratine 18 (CK18), a general epithelial cell marker, and low levels of SP-C, a lung epithelial cell marker (Figure 2a ). These cells grew normally at 33 1C (Figure 2c , blue line) and expressed Ki67 (Figure 2d these findings suggest that p44/wdr77 was sufficient to drive the growth of quiescent lung epithelial cells.
P44/wdr77 expression is essential for lung epithelial cell growth Immunostaining revealed that primary epithelial cells isolated from the lungs of mice carrying the floxed (loxP-flanked) P44/wdr77 gene locus expressed both CK18, a general epithelial cell marker, and SP-C, a lung epithelial cell-specific marker (Figure 3a) . We then infected these epithelial cells with a green fluorescent protein-expressing adenovirus (control) or an adenovirus harboring Cre recombinase to delete the p44/wdr77 gene. We examined p44/wdr77 expression in lung tumor samples from 35 patients (15 adenocarcinomas, 15 squamous cell carcinomas and 5 small cell lung carcinomas) and in benign tissue samples from the same patients. Immunostaining experiments revealed that p44/wdr77 expression was absent from alveolar ducts as well as benign epithelium (Figure 4b , top left panels). However, strong p44/wdr77 immunostaining was present in all tumor samples but absent from the stromal cells surrounding the tumors (Figure 4b ). These results indicated that expression of p44/wdr77 might have contributed to lung tumorigenesis.
Silencing p44/wdr77 expression decreases lung cancer cell growth in tissue culture To determine whether p44/wdr77 has a causal role in lung tumor growth, we silenced p44/wdr77 expression in lung cancer cells. Specifically, we designed short hairpin RNAs (shRNAs) targeted against 5 sequences in the coding region of the human p44/wdr77 gene and infected PC14P lung cancer cells with a lentiviral vector containing a DNA segment specifying the shRNA sequences. We also introduced a nontargeting (NT) control shRNA, whose sequence did not match that of any known human gene, into lung cancer cells. As we anticipated, western blot analysis revealed that the control shRNA did not reduce p44/wdr77 expression ( Figure 5a , lane 1). However, p44/wdr77 shRNAs 1, 2 and 3 dramatically reduced p44/wdr77 protein expression in PC14P cells 4 days after lentiviral infection ( Figure 5a , lanes 2, 3 and 4 versus lane 1), and the combination of p44/wdr77 shRNAs 1 and 3 reduced p44/wdr77 protein expression by 89% compared with that of the control shRNA (lane 7 versus lane 1). The combination of p44/ wdr77 shRNAs 1 and 3 also dramatically decreased p44/wdr77 protein expression in A549 and PC14GL lung cancer cells (Figure 7a , lanes 10 and 13).
We plated cells expressing the NT shRNA or p44/wdr77 shRNAs in 24-well plates and counted them every day. Silencing p44/ wdr77 expression with p44/wdr77 shRNA 1, 2 or 3 inhibited PC14P cell growth (Figure 5b , left panel). Silencing p44/wdr77 expression with p44/wdr77 shRNAs 1 and 3 inhibited PC14P cell growth more dramatically than silencing with p44/wdr77 shRNA 1, 2 or 3 alone did, and this inhibition was correlated with the strong ability of p44/wdr77 shRNAs 1 and 3 to individually silence p44/wdr77 expression. Silencing p44/wdr77 expression with p44/wdr77 shRNAs 1 and 3 also significantly inhibited A549 and PC14GL cell growth (Figure 5b P44/wdr77 expression is essential for lung adenocarcinoma cell growth in an orthotopic lung cancer model To determine the effects of p44/wdr77 silencing on lung cancer, we observed the growth of orthotopic tumors in mice formed from PC14P and PC14GL cells expressing NT shRNA or p44/wdr77 shRNAs. Bioluminescent imaging revealed that tumors developed in all mice (n ¼ 6) 5 weeks after we injected them with the NT shRNA-expressing PC14GL cells (Figures 6a and b) . However, no tumors developed in the mice (n ¼ 6) that we injected with PC14GL cells expressing p44/wdr77 shRNAs. Mice injected with cells expressing NT shRNA had large, macroscopically visible lung tumors, whereas those injected with cells expressing p44/wdr77 shRNA did not (Figures 6c and d) . These results suggested that Figure 5 . Silencing of p44/wdr77 expression inhibits lung cancer cell growth. (a) shRNA-mediated silencing of p44/wdr77 expression in lung cancer cells. Western blot analysis of whole cell lysates from PC14P, A549 and PC14GL cells infected with a lentivirus-expressing NT shRNA (lanes 1, 9 and 12) or p44/wdr77 shRNAs (lanes 2-7, 10, 11 and 13). Western blot analyses of A549 cells infected with a lentivirus-expressing p44/wdr77 shRNAs 1 plus 3 and lentivirus-expressing shRNA-resistant p44/wdr77 are shown in lane 11. (b) Growth curves of lung cancer cells expressing NT shRNA, p44/wdr77 shRNAs or p44/wdr77 shRNA plus shRNA-resistant p44/wdr77. Differences between control and experiment samples were analyzed by unpaired Student's t-test and the P-values are o0.0001.
loss of p44/wdr77 expression abolished lung adenocarcinoma tumor formation.
To exclude the possibility that the observed inhibitory effect of lung tumors by p44/wdr77 silencing was specific to PC14 lung adenocarcinoma tumor cells, we also examined orthotopic lung tumor growth in mice injected with NT shRNA-or p44 shRNAexpressing A549 lung adenocarcinoma cancer cells. Large, macroscopically visible tumors were found in the lungs of mice (n ¼ 13) 21 days after we injected them with NT shRNA-expressing A549 cells. However, no tumors were detected in the lungs of mice (n ¼ 8) injected with p44/wdr77 shRNA-expressing A549 cells. We found many macroscopically visible tumors in the lungs of mice (n ¼ 6) 45 days after injecting them with NT shRNA-expressing A549 cells but no visible tumors in the lungs of mice (n ¼ 6) injected with p44/wdr77 shRNA-expressing cells. The average weight of the lungs of the mice injected with NT shRNAexpressing A549 cells (361 mg) was higher than that of the lungs of mice injected with p44/wdr77 shRNA-expressing A549 cells (233 mg; Figure 7b ), indicating the presence of massive tumors in the lungs of mice injected with control A5489 cells. Hematoxylin and eosin staining revealed a few microscopic tumors in the lungs of mice (n ¼ 6) 45 days after the injection of p44/wdr77 shRNAexpressing A549 cells (Figure 7a, left panel) .
Immunostaining revealed that p44/wdr77 expression was high in A549 cells (Figure 7c , left panel), dramatically decreased by p44/wdr77 shRNA expression (middle panel) and restored by shRNA-resistant p44/wdr77 expression (right panel). The presence of microscopic tumors in the lungs of mice injected with p44/wdr77 shRNA-expressing cells may have been caused by the shRNA's incomplete suppression of p44/wdr77 expression because of variable numbers of integrated shRNA-expressing proviral vectors generated by lentiviral infection in individual cells. Therefore, we analyzed the expression of p44/wdr77 in p44/wdr77 shRNA-and NT shRNA-expressing tumors. The levels of protein expression in p44/wdr77 shRNA-expressing lung tumors and NT shRNAexpressing lung tumors were similar (Figure 7d ). These findings suggested that the incomplete suppression of p44/wdr77 expression by shRNAs in a small subset of p44/wdr77 shRNA-expressing A549 cells accounted for the ability of those cells to form lung tumors. Loss of p44/wdr77 expression leads to cell cycle arrest at the G 1 phase Flow cytometry analysis revealed no difference in the degree of apoptosis between cells expressing NT shRNA and cells expressing p44/wdr77 shRNA, indicating that the loss of p44/wdr77 expression did not induce apoptosis in lung cancer cells. We used a BrdU incorporation assay to measure the proliferation of lung cancer A549 cells. The percentages of BrdU-positive control lung cancer cells (mean ± s.e.m., 82 ± 6%) were higher than those of p44/wdr77 shRNA-expressing lung cancer cells (mean ± s.e.m., 15 ± 1.2%), indicating that the downregulation of p44/wdr77 expression inhibited the proliferation of lung cancer cells.
We next sought to determine whether loss of p44/wdr77 expression affected cell cycle progression in lung epithelial and lung cancer cells. Flow cytometry analysis of propidium iodidestained cells revealed that the proportions of p44/wdr77 shRNAexpressing lung cancer cells and p44-null lung epithelial cells in the G 1 phase were significantly higher than those of the control cells ( Table 1 ). The proportion of p44/wdr77 shRNA-expressing cells in the G 1 phase was 424% higher than the proportion of control cells in the G 1 phase, and the proportion of p44/wdr77 cells in the S phase was lower than the proportion of control cells in the S phase. Thus, the slow growth of p44/wdr77 shRNAexpressing cells and p44-null lung epithelial cells may be attributed to the arrest of cell cycle at the G 1 phase. Consistent with these findings, DNA microarray expression profiling analysis Abbreviations: shRNA, short hairpin RNA; GFP-Ad, GFP-adenovirus; Cre-Ad, Cre-adenovirus.
P44/WDR77 in lung Z Gu et al revealed that the expression of genes whose function is involved in cell cycle progression was downregulated in the p44 shRNAexpressing cells (Supplementary Figure S5) . We also sought to identify the potential mechanisms by which silencing of p44/wdr77 expression caused the growth of cells to be arrested at the G 1 phase. Functional proteomic analysis of NT shRNA-and p44/wdr77 shRNA-expressing A549 cells revealed that silencing of p44/wdr77 expression increased p21 expression (Supplementary Figure S2) . Silencing p44/wdr77 expression also increased the expression of p21 mRNA and protein in A549 and PC14P cells ( Figure 8A , lane 2; Supplementary Figure S3 and S4) and in developing lung tissue samples from mice (Supplementary Figure S3) . p44/wdr77 shRNA induced Rb mRNA expression (Supplementary Figure S3) but not Rb protein expression ( Figure 8A , top panel, lanes 4 and 5) in A549 cells. Silencing of p44/wdr77 reduced the phosphorylation of Rb at amino acid residues 807, 811 and 795 ( Figure 8A, lanes 4, 5) . Expression of the p21 gene can be induced under many conditions that inhibit cell growth via cell cycle arrest at the G 1 phase, and overexpression of p21 induces cell cycle arrest. [17] [18] [19] [20] The Rb protein is a tumor suppressor, and has a pivotal role in the negative control of the cell cycle and in tumor progression. One of the major activities of Rb in undifferentiated cells is negative regulation of the E2F family of transcriptional factors, which prefers to activate S-phase genes. 21 Rb protein is responsible for a major G 1 checkpoint at which Rb can interact with E2F proteins to block cells from entering the S phase and thus inhibit cell growth. The phosphorylation of Rb abolishes its interaction with E2F proteins, thereby relieving its inhibitory effect on cell cycle progression. Rb overexpression induces cell cycle arrest. [22] [23] [24] Consistent with these results, DNA microarray expression profiling analysis revealed that the expression of the E2F1 target genes was downregulated in p44 shRNA-expressing A549 cells (Supplementary Figure S6 ).
To determine whether p21 or/and Rb were responsible for the cell growth inhibition mediated by the silencing of p44/wdr77 expression, we designed shRNAs to silence the expression of p21 (Figure 8a, lane 3) and Rb (Figure 8a, lane 7) in A549 cells. Silencing the expression of p21 or/and Rb partially abolished the growth inhibition induced by p44/wdr77 silencing in A549 cells (Figure 8b ). p21 overexpression-induced inhibition of A549 cell growth did not reach the level achieved by silencing p44/wdr77 expression (Figure 8c) . Thus, one mechanism by which the silencing of p44/wdr77 induces cell cycle arrest is through the Figure 8 . p44/wdr77 targets p21-Rb signaling to control lung cancer cell growth. (a) Western blot analysis of whole-cell lysates derived from A549 cells expressing NT shRNA, p44/wdr77 shRNA, p44/wdr77 shRNA plus p21 shRNA, or Rb shRNA stained with anti-p21, anti-Rb, anti-Rb phospho807/811, anti-Rb phospho795, or anti-actin antibodies. (b) Growth curves of A549 cells infected with a lentivirus-expressing p21, lentivirus-expressing NT shRNA, lentivirus-expressing p44 shRNA, lentivirus-expressing p44 plus p21 shRNAs, lentivirus-expressing p44 plus Rb shRNAs, or lentivirus-expressing p44 shRNA, p21 shRNA, and Rb shRNA. Differences between control and experiment samples were analyzed by unpaired Student's t-test and the P-values are o0.0001. (c) Growth curves of A549 cells infected with a control lentivirus, lentivirusexpressing p21 or lentivirus-expressing p44 shRNA are shown. The insert shows western blot analysis of A549 cells infected with a control lentivirus-(WT), lentivirus-expressing p21 (WT þ p21) or lentivirus-expressing p44/wdr77 shRNA (MT). Differences between control and experiment samples were analyzed by unpaired Student's t-test and the P-values are o0.0001. P44/WDR77 in lung Z Gu et al induction of p21 expression followed by the inhibition of Rb phosphorylation and E2F-dependent transcription.
DISCUSSION
We found that p44/wdr77 expression is essential for the growth of lung epithelial cells and orthotopic lung adenocarcinoma tumors. Loss of p44/wdr77 expression in lung epithelial cells and lung adenocarcinoma cancer cells led to G 1 cell cycle arrest via the p21-Rb-E2F signaling pathway. Our findings suggest an important role of p44/wdr77 in lung development and tumorigenesis.
P44/wdr77 is essential for growth of lung epithelial cells
The results of the present study suggest that p44/wdr77 has essential roles in cell proliferation in the lung. Specifically, we found that p44/wdr77 expression was associated with the proliferation of lung epithelial cells. p44/wdr77 is in abundance in lung epithelial cells harvested from mice during the early stages of development, when cells are proliferating, and in growing immortalized temperature-sensitive lung ECs (LTA ts ). In contrast, p44/wdr77 expression was absent from adult lung epithelial cells and immortalized growth-arrested lung ECs (LTA ts ). In addition, we found that p44/wdr77 expression was sufficient to promote the proliferation of immortalized growth-arrested lung ECs (LTA ts ) at a nonpermissive temperature. Finally, we found that deletion of the p44/wdr77 gene abolished the growth of murine lung epithelial cells. These results are strong evidence that p44/wdr77 is essential and sufficient for the growth of lung epithelial cells.
During the development of a multicellular organism, cells proliferate for a defined length of time before they begin to differentiate functionally. [25] [26] [27] Terminal cell division must be precisely regulated to ensure that the proper numbers of differentiated cells are produced at the appropriate times. Although the control of proliferation and differentiation is highly coordinated, certain differentiation decisions are not compatible with continued proliferation. P44/WDR77 would have an essential role in these processes.
The presence of p44/wdr77 in the cytoplasm of prostate epithelial cells is required for their proliferation during the early stages of prostate development. 8 In contrast to the role of p44/ wdr77 in the lung, p44/wdr77 is expressed in epithelial cells in the adult prostate, and localizes in the nucleus as an androgen receptor cofactor to drive the differentiation of prostate epithelial cells. 7, 8 In the present study, we found that loss of p44/wdr77 expression enhanced SP-C expression in lung epithelial cells and led to the differentiation of lung epithelial cells, which suggests that loss of p44/wdr77 expression is essential to the differentiation of epithelial cells during lung development. Loss of p44/wdr77 expression also caused significant cell enlargement (Supplementary Figure S7 ). P44/wdr77 is essential for cell cycle progression through the G 1 phase We also found that p44/wdr77 was essential for lung epithelial cells to progress through the G 1 phase. The process of differentiation of primitive cells into more specialized cells involves an increasing restriction in proliferation capacity, culminating in cell cycle exit. Maintenance of cell cycle arrest in terminally differentiated cells is important for the ultimate architecture and function of specific tissues. Whether a cell will differentiate into one or another cell type is usually determined at the G 1 phase of the cell cycle. Consistent with these studies, loss of p44/wdr77 expression inhibited the proliferation of lung epithelial cells and lung adenocarcinoma (A549 and PC14P) cells via the arrest at the G 1 phase.
p44/wdr77 modulates the expression of key cell cycle regulators to regulate cell cycle progression. The loss of p44/wdr77 expression increased p21 expression in lung epithelial cells and lung adenocarcinoma cells. p21 is best known for its importance to several processes requiring cell cycle arrest, particularly in cells with DNA damage caused by genotoxic agents.
28 P21 may also be important to the maintenance of cell cycle arrest in differentiated cells. 29, 30 The forced expression of p21 and p16 is sufficient to promote cell cycle withdrawal and the expression of certain differentiation markers. 31, 32 Conversely, the overexpression of cyclin D1 or E2F1 inhibits cell cycle exit and cell differentiation. 31, 33, 34 Lens fiber cell differentiation is severely impaired in mice that are p27-and p57-deficient, 35 and investigators have observed failure of myogenesis in p21 and p57 double-null mice. 36 Taken together, these results suggest that p21 expression-induced cell cycle exit is required for differentiations.
The regulated transcription of genes required for cell cycle progression provides an additional level of cell proliferation control. E2F transcriptional factors have a major role in the regulation of this gene transcription. The expression of E2F-regulated genes is generally increased during late G 1 and/or in S phase of the cell cycle. Rb and its family members p107 and p130 are believed to ensure cell cycle exit and prevent cells from re-entering the cell cycle, mainly by binding to E2F transcription factors, inhibiting the expression of E2F target genes and remodeling chromatin into an inactive state. [37] [38] [39] In the presence of mitogens, cyclin-Cdk complexes phosphorylate Rb family members, relieving the inhibition of E2F targets and enabling S-phase entry. The compromised ability of cells with mutations in the Rb pathway to be arrested at the G 1 phase is thought to be the major basis for its tumor suppressor activity. 40 In the present study, loss of p44/wdr77 expression decreased the phosphorylation of Rb and led to the activation of Rb. Activation of DNA synthesis by the adenovirus E1A in differentiated muscle cells is not simply based on targeting of Rb; E1A also has to bind to and inactivate p21, indicating that both p21 and Rb are required to prevent S phase re-entry in these cells. 41 In proliferating cells, p21 preferentially inhibits cyclin-dependent kinases that are involved in promoting cells into S phase and in augmenting the phosphorylation of Rb protein. 42 Rb functions downstream of p21, and the activities of these two proteins in sustaining their postmitotic states may be linked. 41 Our finding that p44/wdr77 regulated cell cycle progression via p21 and Rb does not exclude the possibility that p44/wdr77 activates additional cellular functions during lung development and lung tumorigenesis. P44/wdr77 is required for growth of lung cancer Our findings suggest that p44/wdr77 has an important role in lung cancer. Tumor cells do not differentiate normally and have an unlimited capacity to proliferate. p44/wdr77 likely exerts the same biological activities during tumorigenesis as it does during normal lung development. We detected the re-expression of p44/wdr77 in lung cancer samples, which suggests that p44/wdr77 has an important role in the proliferation of lung cancer cells. Indeed, p44/wdr77 silencing dramatically inhibited lung adenocarcinoma cell growth in tissue culture and abolished the growth of lung adenocarcinoma xenografts in nude mice. Thus, p44/wdr77 expression is also essential for lung adenocarcinoma growth.
The molecular events that cause terminally differentiated lung epithelial cells to re-enter the cell cycle remain unidentified; however, our findings suggest that the re-expression of p44/ wdr77 is essential to this process. These cells are susceptible to genetic mutations that lead to lung cancer. Our findings also suggest that p44/wdr77 expression and its downstream effectors are novel targets for the prevention and treatment of lung cancer. However, the ways in which this developmental program is reactivated in lung cancer cells remains unknown. Our current work is focused on the regulatory networks controlling p44/wdr77 P44/WDR77 in lung Z Gu et al expression during lung development, which may give us some clues about lung tumorigenesis. Current analyses using two lung adenocarcinoma cell lines (A549 and PC14P) suggest that p44/ wdr77 contributes to lung adenocarcinoma development. Further studies are needed to investigate whether p44/wdr77 also contributes to the development of other subtypes of lung cancers.
MATERIALS AND METHODS
Lung tumor samples and immunohistochemical analysis of p44/ wdr77 expression Lung tumor samples obtained from patients who underwent surgery at Tangdu Hospital (Xi'an, China), and the study protocol was approved by its institutional review board. Samples were fixed with 10% formalin for 24 h and then embedded in paraffin. Paraffin-embedded lung tissue sections (4 mm) were stained with hematoxylin and eosin and used for histological analysis. Lung sections were blocked with 1% fish gel and incubated with a rabbit polyclonal anti-p44/wdr77 antibody (1:1000) overnight at 4 1C. A streptavidin-biotin peroxidase detection system for use with prostate tissues (DAKO A/S, Grostrup, Denmark) was used according to the manufacturer's instructions; 3,3 0 -diaminobenzidine was used as the substrate. The primary antibody was omitted in the negative controls.
Cell culture and cell growth assay A549, PC14P and PC14GL cells were cultured in RPMI 1640 medium (Cellgro, Manassas, VA, USA) with 10% (v/v) fetal bovine serum (HyClone, Logan, VT, USA). PC14GL cells express luciferase and were derived from PC14P cells. For a cell growth assay, cells were plated on 24-well plates (5000 cells/well) and counted every day. For a BrdU incorporation assay, cells (50-70% confluent) were placed on coverslips and cultured with 10 mM BrdU (Sigma-Aldrich, St Louis, MO, USA) for 4 h. The BrdU-labeled cells were detected using staining with a monoclonal anti-BrdU antibody (BD, Franklin Lakes, NJ, USA).
Orthotopic tumors
Lung cancer cells were maintained in RPMI 1640 medium containing 10% fetal bovine serum. Cells in the exponential phase of growth were harvested via treatment with a 0.25% trypsin-0.025 ethylenediaminetetraacetic acid solution for 1 min, and the resulting cell suspension was gently agitated to produce a single-cell suspension. Cells exhibiting 495% viability as ascertained using trypan blue staining were used for injections. Cells were washed with Hank's balanced salt solution and resuspended in Hank's balanced salt solution diluted with an equal volume of growth factor-reduced Matrigel (Becton Dickinson). Cell suspensions were kept on ice until injection.
Six-week-old nude mice were purchased from the National Cancer Institute and maintained in a barred animal facility. An intraperitoneal injection of sodium pentobarbital (50 mg/kg) was used to anesthetize the mice before lung tumor cell injection. Cells (1 Â 10 6 /50 ml) were then injected into the left lateral thorax at the lateral dorsal axillary line using a 30-gauge needle. After the tumor cell injection, the mice were turned to the left lateral decubitus position and observed for 45-60 min until they recovered fully. Mice injected with PC14P or PC14GL cells were killed 35 days after tumor cell injection, and mice injected with A549 cells were killed 21 or 45 days after tumor cell injection. The lungs of the mice were then removed, evaluated for tumors, and fixed with formaldehyde. Mice were handled in accordance with the guidelines published in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The MD Anderson Institutional Animal Care and Use Committee approved all the experimental procedures used for mice.
Bioluminescent imaging
Bioluminescent imaging of lung tumors was conducted using a cryogenically cooled imaging system coupled with a data acquisition computer running the LivingImage software program (Xenogen Corp., Alameda, CA, USA). Before imaging, animals were anesthetized with a 1.5% isoflurane/air mixture in an acrylic chamber, and injected intraperitoneally with 40 mg/ml luciferin potassium salt in phosphate-buffered saline (PBS) at a dose of 150 mg/kg body weight. A digital grayscale animal image was acquired, followed by the acquisition and overlay of a pseudocolor image representing the spatial distribution of detected photons emerging from active luciferase within each animal. Signal intensity was quantified as the sum of all detected photons within the region of interest per second. After the final tumor imaging study, the mice were killed, and normal lung and lung tumor tissues were resected and fixed with formaldehyde. The resected tumors were histologically evaluated to verify the accuracy of the bioluminescent imaging data. Mice were handled in accordance with the guidelines published in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The MD Anderson Institutional Animal Care and Use Committee approved all the experimental procedures used for mice.
Real-time PCR
Total RNAs were isolated from cultured cells using TRIzol reagent and reverse transcribed into cDNA using the Reaction Ready First Strand cDNA Synthesis Kit (SuperArray Bioscience Corp., Valencia, CA, USA). The cDNA products were PCR-amplified with the RT 2 Real-Time SYBR Green PCR master mix and the gene-specific primer sets for human and murine p21, Rb, and b-actin genes (SuperArray Bioscience Corp.) using a SmartCycler II (Cepheid, Sonnyvale, CA, USA; 40 cycles of 30 s at 941C, 20 s at 551C and 30 s at 721C). The SmartCycler software program (version 2.0C) was used to process and quantify raw data. The 2 À DDCT method was used to relatively quantify target gene expression as described previously. 43 The fold change in gene expression equaled the relative quantification of expression level in the p44/wdr77 shRNA group divided by the relative quantification in the NT shRNA group.
RNA interference P44/WDR77 shRNA (target sequence 1: 5 0 -GGGAACTAGATGAGAATGA-3 0 ; target sequence 3: 5 0 -GTGGACACCAAGAGTACAA-3 0 ), p21 shRNA (target sequence: 5 0 -AATAATTAAGACACACAAA-3 0 ), Rb shRNA (target sequence: 5 0 -TGTAAGATCTCCAAAGAAA-3 0 ) and an NT shRNA (target sequence: 5 0 -TTCTCCGAACGTGTCACGT-3 0 ) were designed with a hairpin and sticky ends (ClaI and MluI). The oligonucleotides were annealed into pLVTHM, the lentiviral gene transfer vector using the ClaI and MluI restriction enzyme sites. The DNA was sequenced to determine the proper insertion points and insert lengths. The lentivirus was then produced by transfecting 293T human embryonic kidney cells (Invitrogen, Grand Island, NY, USA) with the sequence-verified PLVTHM vector, the packaging plasmid (MD2G), and the envelope plasmid (PAX2) required for viral production. Three days after transfection, the viral supernatant was collected and filtered to remove cellular debris. A549, PC14P or PC14GL cells were plated at 60% confluence in 6-well plates and transduced with the lentivirus. After 16 h, the viruscontaining medium was removed and replaced with a normal growth medium. Three days after infection, cells were split at 1:6 and allowed to grow for 3 days. Whole-cell lysates (20 mg of protein) from the infected cells were subjected to western blot analysis, and the mRNAs isolated from the infected cells were subjected to real-time PCR.
Nontargetable p44/wdr77 expression The nucleotide sequences targeted by p44/wdr77 shRNAs 1 and 3 were mutated using an oligo-directed mutagenesis kit to create a nontargetable p44/wdr77 expression vector. The target sequences 5 0 -GGGAACTAGATGAG AATGA-3 0 and 5 0 -GTGGACACCAAGAGTACAA-3 0 of p44/wdr77 were mutated to 5 0 -GGGAAtTgGAtGAGAATGA-3 0 and 5 0 -GTGGACACCAAatcaACAA-3 0 . The mutant p44/wdr77 cDNA was subcloned into a lentiviral expression vector. This recombinant lentivirus was produced with 293T cells as described above. To restore p44/wdr77 expression, p44/wdr77 shRNA-or NT shRNAexpressing A549 cells were plated in 6-well plates and transduced with a lentivirus containing either the nontargetable p44/wdr77 expression vector or an empty vector. The cells were replated after 48 h, and p44/ wdr77 expression was confirmed using western blot analysis.
Mouse lung preparation C57BL6/J mice (n ¼ 30) were killed at the age of 1, 7, 14, 30, 120 or 390 days, and their lungs were dissected. Half of each lung was used to make protein extracts and total RNA, and the other half was fixed by immersion in 4% paraformaldehyde in PBS for 60 min. The fixed lung tissues were then embedded in paraffin, and 4-mm sections were cut and mounted on Superfrost Plus adhesion slides (Fisher, Pittsburgh, PA, USA) for hematoxylin and eosin and immunohistochemical staining. Mice were handled in accordance with the guidelines published in the National The blots were then incubated with a horseradish peroxide-conjugated secondary antibody for 1.5 h. Immunoreactive proteins were detected using an enhanced chemiluminescence detection system (GE Healthcare, Waukesha, WI, USA) per the manufacturer's instructions. Protein concentrations were determined using the Bradford protein assay (Bio-Rad, Hercules, CA, USA). The protein bands were scanned using a densitometer, and the relative intensities were quantified using the ImageJ software program (ImageJ64, National Institutes of Health, Bethesda, MD, USA).
Immunohistochemistry
Formalin-fixed, paraffin-embedded murine lung sections were deparaffinized by sequential washing with xylene, graded ethanol and PBS. Antigens were retrieved from the sections by heating the sections plus 1 Â Target Retrieval Solution (Dako) in a steam cooker for 30 min. The sections were then cooled and washed with PBS. Endogenous peroxide in lung tissues was blocked with 3% hydrogen peroxidase inhibitor in PBS for 12 min. Nonspecific proteins were blocked in 5% horse serum and 1% goat serum for 20 min. Slides were incubated with an anti-p44/wdr77 (1:400) or antiKi67 antibody overnight at 4 1C and then incubated with a peroxidaselabeled anti-rabbit antibody (1:500; Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at room temperature. Signals were detected by staining the sections with 3, Cultured cells were allowed to grow on chamber slides and fixed with cold methanol ( À 20 1C) for 10 min. Nonspecific proteins were blocked with 4% fish gelatin in PBS for 20 min. The cells were incubated with the primary antibodies described above at 4 1C overnight and then incubated with goat anti-rat Alexa 595 (1:500; Invitrogen) at room temperature for 1 h. The cells were then washed with PBS, counterstained with SYTOX Green (Molecular Probes, Grand Island, NY, USA) for 10 min at room temperature, and mounted in Histogel (Linaris Histogel). A fluorescence confocal microscope was used to analyze the cells directly.
Gene expression profiling
Total RNA was extracted from A549 cells using the RNAqueous kit (Ambion, Austin, TX, USA) 4 days after infection of lentivirus-expressing NT shRNA or p44/wdr77 shRNA. After confirmation of RNA quality using a Bioanalyzer 2100 instrument (Agilent, Santa Clara, CA, USA), 300 ng of total RNA was amplified and biotin-labeled through an Eberwine procedure using an Illumina TotalPrep RNA Amplification kit (Ambion), and hybridized to Illumina HT12 version 4 human whole-genome arrays. Processing of bead-level data was by methods previously described. 44 Significance testing for differentially expressed probes was by the Wilcoxon rank-sum test applied to individual processed bead values, with false-discovery rate significance values (q) determined by the method of Benjamini and Hochberg. 45 Hierarchical clustering and heat mapping used Cluster and Treeview software from Eisen et al. 46 Gene set analysis applied gene set enrichment analysis 47 and the hypergeometric distribution test 48 to gene sets from mSigDB and individual literature sources.
Statistical analysis
Data are presented as the means of three or more independent experiments ± the s.e.m. A 2-tailed unpaired Student's t-test was used to determine whether differences between control and experiment samples were statistically significant. P-values o0.05 were considered statistically significant.
